JP2007523093A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523093A5 JP2007523093A5 JP2006553373A JP2006553373A JP2007523093A5 JP 2007523093 A5 JP2007523093 A5 JP 2007523093A5 JP 2006553373 A JP2006553373 A JP 2006553373A JP 2006553373 A JP2006553373 A JP 2006553373A JP 2007523093 A5 JP2007523093 A5 JP 2007523093A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- delivery vehicle
- cholesterol
- liposome delivery
- vehicle comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 10
- 239000002502 liposome Substances 0.000 claims 7
- 150000002632 lipids Chemical class 0.000 claims 6
- 239000003981 vehicle Substances 0.000 claims 6
- 235000012000 cholesterol Nutrition 0.000 claims 5
- 108091034117 Oligonucleotide Proteins 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/780,294 US20050181035A1 (en) | 2004-02-17 | 2004-02-17 | Systemic immune activation method using non CpG nucleic acids |
| PCT/US2005/005336 WO2005079511A2 (en) | 2004-02-17 | 2005-02-17 | SYSTEM IMMUNE ACTIVATION METHOD USING NON CpG NUCLEIC ACIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007523093A JP2007523093A (ja) | 2007-08-16 |
| JP2007523093A5 true JP2007523093A5 (https=) | 2008-04-03 |
Family
ID=34838562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553373A Pending JP2007523093A (ja) | 2004-02-17 | 2005-02-17 | 非ＣｐＧ核酸を使用した全身性免疫活性化法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050181035A1 (https=) |
| EP (1) | EP1718149A4 (https=) |
| JP (1) | JP2007523093A (https=) |
| AU (1) | AU2005215020A1 (https=) |
| CA (1) | CA2556229A1 (https=) |
| WO (1) | WO2005079511A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| EP0855184A1 (en) * | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| ES2572834T3 (es) | 1999-02-17 | 2016-06-02 | Csl Limited | Complejos inmunogénicos y métodos relacionados con los mismos |
| NZ517929A (en) * | 1999-09-25 | 2004-02-27 | Univ Iowa Res Found | Immunostimulatory nucleic acids |
| EP2257306B1 (en) * | 2008-03-25 | 2014-05-07 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
| WO2010130374A1 (en) * | 2009-05-14 | 2010-11-18 | Bayer Animal Health Gmbh | Enhanced immune response in avian species |
| US11576958B2 (en) | 2013-02-07 | 2023-02-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
| KR20160122849A (ko) | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
| CN108064176A (zh) | 2015-04-22 | 2018-05-22 | 库瑞瓦格股份公司 | 用于治疗肿瘤疾病的含有rna的组合物 |
| SG10202000891UA (en) | 2015-07-31 | 2020-03-30 | Bayer Animal Health Gmbh | Enhanced immune response in porcine species |
| KR102069680B1 (ko) * | 2017-03-02 | 2020-01-23 | 단디바이오사이언스 주식회사 | 면역억제인자 제어물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957735A (en) * | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US5043164A (en) * | 1989-01-17 | 1991-08-27 | The University Of Tennessee Research Corporation | Blood-stable, cholesterol-free liposomes |
| US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
| US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5676954A (en) * | 1989-11-03 | 1997-10-14 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
| US5705187A (en) * | 1989-12-22 | 1998-01-06 | Imarx Pharmaceutical Corp. | Compositions of lipids and stabilizing materials |
| US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5643578A (en) * | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| EP0646178A1 (en) * | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| JP3351476B2 (ja) * | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
| US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| DE69429337T3 (de) * | 1993-04-02 | 2012-08-30 | Anticancer Inc. | Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel |
| US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| WO1995026204A1 (en) * | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| EP1167379A3 (en) * | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6239116B1 (en) * | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US5820873A (en) * | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| US5703057A (en) * | 1995-04-07 | 1997-12-30 | Board Of Regents The University Of Texas System | Expression library immunization |
| US5705385A (en) * | 1995-06-07 | 1998-01-06 | Inex Pharmaceuticals Corporation | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| US5981501A (en) * | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
| US5976567A (en) * | 1995-06-07 | 1999-11-02 | Inex Pharmaceuticals Corp. | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| US5830878A (en) * | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
| US5817856A (en) * | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
| US6121247A (en) * | 1996-03-29 | 2000-09-19 | The Johns Hopkins University | Therapy for allergic diseases |
| US5853719A (en) * | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| AU733310C (en) * | 1997-05-14 | 2001-11-29 | University Of British Columbia, The | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| EP1003531B1 (en) * | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US6977245B2 (en) * | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
| US20020156033A1 (en) * | 2000-03-03 | 2002-10-24 | Bratzler Robert L. | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| JP2004501955A (ja) * | 2000-06-30 | 2004-01-22 | アイネックス ファーマシューティカルズ コーポレイション | リポソーム抗新生物薬剤およびその使用 |
| US20030082228A1 (en) * | 2001-05-09 | 2003-05-01 | Inex Pharmaceuticals Corporation | Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents |
| US20040009944A1 (en) * | 2002-05-10 | 2004-01-15 | Inex Pharmaceuticals Corporation | Methylated immunostimulatory oligonucleotides and methods of using the same |
| CA2388049A1 (en) * | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
-
2004
- 2004-02-17 US US10/780,294 patent/US20050181035A1/en not_active Abandoned
-
2005
- 2005-02-17 AU AU2005215020A patent/AU2005215020A1/en not_active Abandoned
- 2005-02-17 EP EP05723350A patent/EP1718149A4/en not_active Withdrawn
- 2005-02-17 JP JP2006553373A patent/JP2007523093A/ja active Pending
- 2005-02-17 WO PCT/US2005/005336 patent/WO2005079511A2/en not_active Ceased
- 2005-02-17 CA CA002556229A patent/CA2556229A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7702159B2 (ja) | 核酸、当該核酸を含む組成物および複合体ならびに調製方法と使用 | |
| JP7459691B2 (ja) | 神経筋障害の治療のための改善された特徴を有するｒｎａ調節オリゴヌクレオチド | |
| Zhang et al. | Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity | |
| Xiao et al. | Hydrophobic interaction: a promising driving force for the biomedical applications of nucleic acids | |
| JP2007523093A5 (https=) | ||
| US5859228A (en) | Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes | |
| JP6685338B2 (ja) | アミン陽イオン性脂質およびその使用 | |
| CN110003066B (zh) | 用于rna递送的可电离的阳离子脂质 | |
| Wilson et al. | Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy | |
| JP6006183B2 (ja) | 増強された免疫刺激活性を有する疎水性Ｔ類似体を含有するＣｐＧオリゴヌクレオチド類似体 | |
| CN101287497B (zh) | 涂层脂质复合体和它们的用途 | |
| EP4114939A2 (en) | Oligonucleotide compositions and methods thereof | |
| CN116693411A (zh) | 用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂 | |
| CN111973617A (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| JP2022519019A (ja) | オリゴヌクレオチド組成物及びその方法 | |
| CN113939592A (zh) | 导入了化学修饰核酸的稳定型目标编辑向导rna | |
| CN118291457A (zh) | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 | |
| CN111979237A (zh) | 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途 | |
| CN111973619A (zh) | 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途 | |
| JP2018527013A5 (https=) | ||
| JP2009514877A5 (https=) | ||
| JP2007509983A (ja) | 免疫刺激力が増強されたｃ−クラスのオリゴヌクレオチドアナログ | |
| CN115819484A (zh) | 双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途 | |
| KR20160117535A (ko) | 생분해성 컨쥬게이트를 갖는 폴리 올리고머 화합물 | |
| JP2009544281A5 (https=) |